Skip to content

DYN

Dyne Therapeutics, Inc.

NASDAQ · USHealthcareBiotechnology
$23.68-0.25%

Price as of Jul 20, 2026

DYN earnings

Dyne Therapeutics, Inc. earnings

Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.

Next earnings
Jul 27, 2026in NaN days
EPS est $-0.74 · Revenue est
Track record
Beat EPS in 6 of 12 quarters
Avg surprise -0.8% (last 4 quarters)
Earnings history
Report dateEPS estEPS actualSurpriseRevenueRev. surprise
May 11, 2026$-0.77$-0.73+5.5%
Nov 5, 2025$-0.81$-0.76+6.2%
May 8, 2025$-0.88$-1.05-19.3%
Feb 27, 2025$-0.92$-0.88+4.3%
May 2, 2024$-0.81$-0.81+0.0%
Mar 5, 2024$-0.92$-1.09-18.5%$4M
Aug 3, 2023$-0.81$-1.08-33.3%
May 11, 2023$-0.77$-0.78-1.3%
Mar 2, 2023$-0.84$-0.74+11.9%
Nov 3, 2022$-0.95$-0.80+15.8%
Aug 4, 2022$-0.79$-1.01-27.8%
May 2, 2022$-0.88$-0.69+21.6%

Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-07-27.